Yiwei Zhang
Hubei University of Medicine(CN)China-Japan Friendship Hospital(CN)Chongqing Institute of Genetics and Reproduction(CN)People's Hospital of Shiyan(CN)Institut de Médecine de la Reproduction(FR)First Affiliated Hospital of Zhengzhou University(CN)Institute of Crop Sciences(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cancer-related Molecular Pathways, Immune Cell Function and Interaction, Genetic Associations and Epidemiology
Most-Cited Works
- → Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial(2019)177 cited
- → A facilely synthesized amino-functionalized metal–organic framework for highly specific and efficient enrichment of glycopeptides(2014)115 cited
- → Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning(2017)112 cited
- → A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53(2012)107 cited
- → Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator(2016)77 cited
- → Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity(2020)68 cited